Biological and pharmacological activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase
- 1 January 1981
- journal article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 6, 10-13
- https://doi.org/10.1016/0968-0004(81)90005-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.The Journal of Antibiotics, 1980
- Synthesis of ubiquinone and cholesterol in human fibroblasts: Regulation of a branched pathwayArchives of Biochemistry and Biophysics, 1979
- Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.The Journal of Antibiotics, 1979
- Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A ReductaseEuropean Journal of Biochemistry, 1978
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- The Role of Polyprenol-Linked Sugars in Glycoprotein SynthesisAnnual Review of Biochemistry, 1976
- Biochemistry of Polyisoprenoid BiosynthesisAnnual Review of Biochemistry, 1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976
- Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Cultured Human FibroblastsJournal of Biological Chemistry, 1974